Posts

1499273714_81-300×169.jpg

Dutch cancer association sues tobacco | DIY E-Liquid Blog – E-Juice Makers


Dutch cancer association sues tobacco industry for murder

The Dutch cancer association KLF filed suit against four multinational tobacco companies, and now lawyers in 17 other countries are following KLF’s lead and considering doing the same.

NL Times reported that lawyers from 15 countries recently gathered in Switzerland to discuss the Dutch lawsuit, and how to pursue their own legal strategies. Representatives from Germany and Belgium are also interested, but were unable to attend the meeting.

The companies being sued are Philip Morris International, British American Tobacco, Japan Tobacco International and Imperial Tobacco. The Netherlands’ public prosecutor (equivalent to an attorney general) will decide by August if the country itself will prosecute the case.

De Kanter maintains that nicotine is as addictive as cocaine and heroin.

The Dutch case is the idea of Dutch lawyer Benedicte Ficq and lung cancer specialist Dr. Wanda de Kanter, a well-known tobacco control extremist who is opposed not just to cigarettes and the tobacco industry, but also anything that resembles smoking (like vaping) and any form of tobacco harm reduction.

De Kanter maintains that nicotine is as addictive as cocaine and heroin, according to Dutch vaping advocacy group Acvoda. Of course, there is ample evidence that nicotine without smoke is nowhere near as addictive as those drugs.

Ficq, de Kanter, KWF, and lung cancer victim Anne Marie van Veen are bringing charges of attempted murder or manslaughter, attempted aggravated assault with premeditation, attempted deliberate harm to health with premeditation, and forgery.

The post Dutch cancer association sues tobacco industry for murder appeared first on Vaping360.

#vaping

Dutch cancer association sues tobacco industry for murder – Vaping360

 


Source

img8.png

Pharma Industry insider and advocate of reduced regulation picked to head FDA but not even more pro-antiaging O’Neill


Pharma Industry insider and advocate of reduced regulation picked to head FDA but not even more pro-antiaging O’NeillPresident Trump as nominating Dr. Scott Gottlieb to be Commissioner of the Food and Drug Administration (FDA). Gottlieb is a medical doctor and former FDA deputy commissioner.
Gottlieb has advocated speeding up the approval complex generics — cheaper, copycat versions of products such as Mylan’s allergy jab, the EpiPen, and Copaxone, an injection for multiple sclerosis from Teva, which both command high prices.
Dr Gottlieb is a cancer survivor who survived cancer.
He advocates patient power and backs several reforms that would make it easier for some drugs to secure approval.
More medicines could be designated as “breakthrough” treatments to get faster approval.
He supports the conditional or “accelerated” approval of medicines based on early evidence gathered during smaller clinical trials, rather than waiting for the conclusion of longer studies that provide more definitive proof.Gottlieb would bring a strong pro-industry, deregulatory approach to an agency that Trump has criticized as being overly restrictive. But he is also likely to support one of the agency’s basic functions: to ensure that drugs are proven safe and effective before they are sold.
His selection is a victory for the mainstream pharmaceutical industry, which has little appetite for upending the FDA approval process. Even many Democratic critics of the drug industry, and of Gottlieb himself, privately indicated they strongly preferred him to another frequently mentioned contender, Jim O’Neill, an associate of Silicon Valley billionaire and Trump adviser Peter Thiel. In a 2014 speech, O’Neill called for allowing drugs to be marketed after they were proven safe, but before they were shown to be effective.Read more »

Pharma Industry insider and advocate of reduced regulation picked to head FDA but not even more pro-antiaging O’Neill

 


Source